CPRX (CPRX) R&D Ratio: Latest Data, Historical Trends & Peer Comparison
What is CPRX's (CPRX) R&D Ratio?
For the trailing twelve months (TTM) ended Mar 31, 2026, CPRX R&D Ratio was 1.92%, representing a -26.3% change year over year.
For fiscal Q1'26 ended Mar 31, 2026, CPRX R&D Ratio was 1.78%, representing a -35.19% change year over year.
R&D Ratio Historical Trend for CPRX
View CPRX's annual, quarterly, and TTM R&D Ratio data from 2018 to 2026, including historical growth rates and trend analysis.
CPRX TTM Data
| Metric | Q4'18Dec 31, 2018 | Q1'19Mar 31, 2019 | Q4'19Dec 31, 2019 | Q1'20Mar 31, 2020 | Q2'20Jun 30, 2020 | Q3'20Sep 30, 2020 | Q4'20Dec 31, 2020 | Q1'21Mar 31, 2021 | Q2'21Jun 30, 2021 | Q3'21Sep 30, 2021 | Q4'21Dec 31, 2021 | Q1'22Mar 31, 2022 | Q2'22Jun 30, 2022 | Q3'22Sep 30, 2022 | Q4'22Dec 31, 2022 | Q1'23Mar 31, 2023 | Q2'23Jun 30, 2023 | Q3'23Sep 30, 2023 | Q4'23Dec 31, 2023 | Q1'24Mar 31, 2024 | Q2'24Jun 30, 2024 | Q3'24Sep 30, 2024 | Q4'24Dec 31, 2024 | Q1'25Mar 31, 2025 | Q2'25Jun 30, 2025 | Q3'25Sep 30, 2025 | Q4'25Dec 31, 2025 | Q1'26Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R&D Ratio YoY | 3.98K% -- | 154.21% -- | 18.42% -99.54% | 16.60% -89.23% | 16.26% -- | 15.76% -- | 13.85% -24.78% | 12.72% -23.4% | 12.12% -25.48% | 12.07% -23.43% | 12.03% -13.2% | 11.28% -11.35% | 9.89% -18.37% | 10.79% -10.62% | 9.24% -23.18% | 7.78% -31.02% | 6.58% -33.54% | 27.35% +153.46% | 23.39% +153.21% | 22.41% +188.09% | 20.99% +219.25% | 2.35% -91.41% | 2.57% -89% | 2.61% -88.35% | 2.74% -86.93% | 2.54% +8.18% | 2.16% -16.11% | 1.92% -26.3% |
CPRX Quarterly Data
| Metric | Q4'18Dec 31, 2018 | Q1'19Mar 31, 2019 | Q2'19Jun 30, 2019 | Q3'19Sep 30, 2019 | Q4'19Dec 31, 2019 | Q1'20Mar 31, 2020 | Q2'20Jun 30, 2020 | Q3'20Sep 30, 2020 | Q4'20Dec 31, 2020 | Q1'21Mar 31, 2021 | Q2'21Jun 30, 2021 | Q3'21Sep 30, 2021 | Q4'21Dec 31, 2021 | Q1'22Mar 31, 2022 | Q2'22Jun 30, 2022 | Q3'22Sep 30, 2022 | Q4'22Dec 31, 2022 | Q1'23Mar 31, 2023 | Q2'23Jun 30, 2023 | Q3'23Sep 30, 2023 | Q4'23Dec 31, 2023 | Q1'24Mar 31, 2024 | Q2'24Jun 30, 2024 | Q3'24Sep 30, 2024 | Q4'24Dec 31, 2024 | Q1'25Mar 31, 2025 | Q2'25Jun 30, 2025 | Q3'25Sep 30, 2025 | Q4'25Dec 31, 2025 | Q1'26Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R&D Ratio YoY | 1.68K% -- | 26.57% -- | 16.05% -- | 14.88% -- | 20.94% -98.76% | 14.49% -45.46% | 14.69% -8.47% | 12.79% -14.05% | 13.46% -35.73% | 9.96% -31.31% | 12.24% -16.72% | 12.48% -2.41% | 13.03% -3.2% | 7.90% -20.67% | 7.50% -38.72% | 14.52% +16.32% | 6.74% -48.3% | 4.17% -47.17% | 3.97% -47.05% | 81.47% +461.23% | 1.78% -73.53% | 2.62% -37.21% | 2.43% -38.73% | 2.55% -96.87% | 2.68% +50.15% | 2.75% +4.9% | 2.97% +22.24% | 1.79% -29.83% | 1.18% -55.79% | 1.78% -35.19% |
CPRX (CPRX) : Definition & Explanation
R&D Ratio shows how large a key operating expense is relative to revenue. It gives investors a quick read on where the company is spending to run, defend, or grow the business.
It matters because r&d ratio can help explain why margins are improving or weakening. In some businesses, a higher ratio can reflect pressure, while in others it can reflect deliberate investment.
This is usually calculated by dividing a reported expense line by revenue for the same period.
Investors usually read r&d ratio alongside revenue growth, gross margin, operating margin, and management commentary. The best interpretation depends on whether the spending is supporting future growth or simply offsetting weaker operating conditions.
CPRX (CPRX) R&D Ratio Related Metrics
Explore key financial metrics related to CPRX's (CPRX) R&D Ratio. Click on the links below to dive deeper into similar and complementary indicators.
About CPRX (CPRX)
CPRX
Industry
--
Established Date
--
Listing Date
--
Exchange
--
Full-time Employees
--
Fiscal Year Ends
--
Website
--
Security Type
--
Office address
--
Business
--
Introduction
--